KESTRA MEDICAL TECHNOLOGIES, LTD.
|
Apr-25 |
Apr-24 |
Apr-23 |
Apr-21 |
Apr-20 |
| Total revenue |
0.06 |
0.03 |
0.01 |
0.00 |
0.00 |
| Cost of revenue |
0.04 |
0.03 |
0.02 |
|
|
| Gross profit |
0.02 |
0.00 |
-0.01 |
|
|
| Selling, general and administrative |
0.11 |
0.03 |
0.02 |
0.01 |
0.01 |
| Research and development |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
| Other operating expenses |
0.00 |
0.04 |
0.03 |
0.00 |
0.00 |
| Operating income |
-0.11 |
-0.09 |
-0.08 |
-0.03 |
-0.03 |
| Non-operating income (net) |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
| Income before tax |
-0.11 |
-0.09 |
-0.08 |
-0.03 |
-0.03 |
| Income tax expense |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net income |
-0.11 |
-0.09 |
-0.08 |
-0.03 |
-0.03 |
Show Quarterly Income Statement
|
Jan-26 |
Oct-25 |
Jul-25 |
Apr-25 |
Jan-25 |
Oct-24 |
Jul-24 |
Apr-24 |
Jan-24 |
Jul-21 |
Jul-20 |
| Total revenue |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
|
|
| Cost of revenue |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
|
|
| Gross profit |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
|
|
| Selling, general and administrative |
0.04 |
0.04 |
0.03 |
0.05 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
|
|
| Research and development |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
| Other operating expenses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
| Operating income |
-0.03 |
-0.03 |
-0.03 |
-0.05 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
| Non-operating income (net) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Income before tax |
-0.03 |
-0.03 |
-0.03 |
-0.05 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
| Income tax expense |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net income |
-0.03 |
-0.03 |
-0.03 |
-0.05 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
|
Apr-25 |
Apr-24 |
Apr-23 |
Apr-21 |
Apr-20 |
| Cash and cash equivalents |
0.24 |
0.01 |
0.01 |
0.02 |
0.01 |
| Short-term investments |
|
|
|
|
|
| Accounts receivable, net |
0.01 |
0.00 |
0.00 |
|
|
| Inventories |
0.01 |
0.00 |
0.00 |
|
|
| Other current assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total current assets |
0.26 |
0.01 |
0.02 |
0.03 |
0.01 |
| Property, plant and equipment, net |
|
|
|
|
|
| Goodwill |
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
| Long-term investments |
|
|
|
|
|
| Other non-current assets |
|
|
|
|
|
| Total assets |
0.30 |
0.05 |
0.04 |
0.03 |
0.01 |
|
| Accounts payable |
0.02 |
0.02 |
0.01 |
0.00 |
0.00 |
| Short-term debt |
0.00 |
|
0.02 |
0.00 |
0.00 |
| Current portion of long-term debt |
|
|
0.02 |
|
|
| Deferred revenue |
|
|
|
|
|
| Other current liabilities |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
| Long-term debt |
0.04 |
0.04 |
0.02 |
0.02 |
|
| Capital lease obligations |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Other non-current liabilities |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Total liabilities |
0.09 |
0.26 |
0.16 |
0.03 |
0.00 |
|
| Common stock and paid-in capital |
0.73 |
0.20 |
0.19 |
0.17 |
0.14 |
| Retained earnings |
-0.52 |
-0.41 |
-0.31 |
-0.17 |
-0.14 |
| Common shares outstanding |
50 |
50 |
50 |
50 |
50 |
Show Quarterly Balance Sheet
|
Jan-26 |
Oct-25 |
Jul-25 |
Apr-25 |
Jan-25 |
Oct-24 |
Jul-24 |
Apr-24 |
Jan-24 |
Jul-21 |
Jul-20 |
| Cash and cash equivalents |
0.29 |
0.18 |
0.20 |
0.24 |
0.05 |
0.08 |
|
0.01 |
|
0.01 |
|
| Short-term investments |
|
|
|
|
|
|
|
|
|
|
|
| Accounts receivable, net |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
|
0.00 |
|
|
|
| Inventories |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
|
0.00 |
|
|
|
| Other current assets |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
|
0.00 |
|
0.00 |
|
| Total current assets |
0.31 |
0.20 |
0.22 |
0.26 |
0.07 |
0.09 |
|
0.01 |
|
0.01 |
|
| Property, plant and equipment, net |
|
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
|
|
|
|
| Long-term investments |
|
|
|
|
|
|
|
|
|
|
|
| Other non-current assets |
|
|
|
|
|
|
|
|
|
|
|
| Total assets |
0.38 |
0.25 |
0.27 |
0.30 |
0.11 |
0.12 |
|
0.05 |
|
0.02 |
|
|
| Accounts payable |
0.02 |
0.02 |
0.02 |
0.02 |
0.03 |
0.02 |
|
0.02 |
|
0.00 |
|
| Short-term debt |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
0.00 |
|
| Current portion of long-term debt |
|
|
|
|
|
|
|
|
|
|
|
| Deferred revenue |
|
|
|
|
|
|
|
|
|
|
|
| Other current liabilities |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
|
0.01 |
|
0.00 |
|
| Long-term debt |
0.04 |
0.04 |
0.04 |
0.04 |
0.04 |
0.04 |
|
0.04 |
|
|
|
| Capital lease obligations |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
|
|
|
| Other non-current liabilities |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
|
|
|
| Total liabilities |
0.09 |
0.08 |
0.08 |
0.09 |
0.37 |
0.36 |
|
0.26 |
|
0.03 |
|
|
| Common stock and paid-in capital |
0.90 |
0.74 |
0.73 |
0.73 |
0.19 |
0.19 |
0.00 |
0.20 |
0.00 |
0.17 |
0.00 |
| Retained earnings |
-0.61 |
-0.58 |
-0.55 |
-0.52 |
-0.47 |
-0.45 |
|
-0.41 |
|
-0.18 |
|
| Common shares outstanding |
53 |
51 |
51 |
50 |
50 |
50 |
50 |
50 |
50 |
50 |
50 |
|
Apr-25 |
Apr-24 |
Apr-23 |
Apr-21 |
Apr-20 |
| Net income |
|
|
|
|
|
| Depreciation, depletion and amortization |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
| Stock-based compensation |
0.02 |
0.00 |
0.00 |
0.00 |
0.00 |
| Change in inventory |
0.00 |
0.00 |
0.00 |
|
|
| Other working capital changes |
-0.11 |
-0.08 |
-0.07 |
-0.03 |
-0.03 |
| Capital expenditures |
-0.02 |
-0.01 |
-0.02 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Dividend payout |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Common stock repurchases |
|
|
|
|
|
| Net Debt Issuance |
0.33 |
0.08 |
0.10 |
0.05 |
0.03 |
|
| Change in cash |
0.23 |
-0.01 |
0.01 |
0.02 |
0.00 |
Show Quarterly Cash Flow
|
Jan-26 |
Oct-25 |
Jul-25 |
Apr-25 |
Jan-25 |
Oct-24 |
Jul-24 |
Apr-24 |
Jan-24 |
Jul-21 |
Jul-20 |
| Net income |
|
|
|
|
|
|
|
|
|
|
|
| Depreciation, depletion and amortization |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Stock-based compensation |
0.01 |
0.01 |
0.00 |
0.02 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Change in inventory |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
|
| Other working capital changes |
-0.03 |
-0.03 |
-0.03 |
-0.05 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
| Capital expenditures |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Dividend payout |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Common stock repurchases |
|
|
|
|
|
|
|
|
|
|
|
| Net Debt Issuance |
0.15 |
0.00 |
0.00 |
0.21 |
0.00 |
0.00 |
0.12 |
0.01 |
0.01 |
0.00 |
0.01 |
|
| Change in cash |
0.12 |
-0.03 |
-0.04 |
0.18 |
-0.02 |
-0.02 |
0.09 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) - Ebit
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) - Net Income From Continuing Operations
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) - Income Tax Expense
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) - Income Before Tax
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) - Depreciation And Amortization
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) - Interest Expense
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) - Interest Income
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) - Net Interest Income
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) - Operating Expenses
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) - Research And Development